Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
- Blood donor screening is now a reporting option for antibody screening results. This change covers the use of HLA testing in blood centers/hospital laboratories for the purpose of donor qualification.
- Three 0.25‑mL plasma specimens; two (approximately 1.0 x 106 cells) purified peripheral blood lymphocyte specimens
Shipment A: January 28
Shipment B: May 19
Shipment C: October 20